Filing Flows › America Great Health (AAGH) › Q3 FY26 › vs Q2 FY26
America Great Health (AAGH) Q3 FY26 vs Q2 FY26 (quarter over quarter)
America Great Health's revenue fell $19K (-42%) from $45K in Q2 FY26 to $26K in Q3 FY26. The biggest changes: Anti Aging Immune Support −$13K (-48%); Targeted System Support −$5K (-32%); Herbal Insulin Support −$2K (-39%).
America Great Health, Q3 FY26: revenue $26K (-53% year over year), operating margin -282.2%, net loss $166K, operating cash flow $2K. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Anti Aging Immune Support | $14K | $27K | −$13K | -48% |
| Targeted System Support | $10K | $14K | −$5K | -32% |
| Herbal Insulin Support | $2K | $4K | −$2K | -39% |
| Revenue | $26K | $45K | −$19K | -42% |
| Net loss | $166K | −$1.1M | $1.3M | — |
| Costs & expenses | $192K | $1.4M | −$1.2M | -86% |
| Operating costs | $100K | $244K | −$144K | -59% |
| Interest & other, net | $92K | −$1.3M | $1.4M | — |
| Cost of revenue | $4K | $9K | −$5K | -58% |
| Operating expenses | $96K | $235K | −$139K | -59% |
| Operating cash sources | $168K | −$1.2M | $1.4M | — |
| Depreciation | $1K | $4K | −$3K | -74% |
| Working capital & other | $167K | −$1.2M | $1.4M | — |
| Net loss absorbed | $166K | −$1.1M | $1.3M | — |
| Operating cash flow | $2K | −$126K | $128K | — |
Questions
How much did America Great Health's revenue grow quarter over quarter in Q3 FY26?
America Great Health's revenue fell $19K (-42%) from $45K in Q2 FY26 to $26K in Q3 FY26.
What drove America Great Health's revenue change in Q3 FY26?
Anti Aging Immune Support −$13K (-48%); Targeted System Support −$5K (-32%); Herbal Insulin Support −$2K (-39%).